These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 11457524

  • 1. Stimulation of either cholecystokinin receptor subtype reduces while antagonists potentiate or sensitize a morphine-induced excitatory response.
    Felicio LF, Mazzini BK, Cacheiro RG, Cruz TN, Flório JC, Nasello AG.
    Peptides; 2001 Aug; 22(8):1299-304. PubMed ID: 11457524
    [Abstract] [Full Text] [Related]

  • 2. Involvement of different subtypes of cholecystokinin receptors in opioid antinociception in the mouse.
    Suh HW, Kim YH, Choi YS, Song DK.
    Peptides; 1995 Aug; 16(7):1229-34. PubMed ID: 8545243
    [Abstract] [Full Text] [Related]

  • 3. Puerperal blockade of cholecystokinin (CCK1) receptors disrupts maternal behavior in lactating rats.
    Miranda-Paiva CM, Nasello AG, Yim AJ, Felicio LF.
    J Mol Neurosci; 2002 Aug; 18(1-2):97-104. PubMed ID: 11931355
    [Abstract] [Full Text] [Related]

  • 4. Differential role of cholecystokinin receptor subtypes in opioid modulation of ongoing maternal behavior.
    Miranda-Paiva CM, Felicio LF.
    Pharmacol Biochem Behav; 1999 Sep; 64(1):165-9. PubMed ID: 10495012
    [Abstract] [Full Text] [Related]

  • 5. Cholecystokinin modulation of apomorphine- or amphetamine-induced stereotypy in rats: opposite effects.
    Tieppo CA, Felicio LF, Nasello AG.
    Peptides; 2001 Aug; 22(8):1291-8. PubMed ID: 11457523
    [Abstract] [Full Text] [Related]

  • 6. Supraspinal neurotensin-induced antianalgesia in mice is mediated by spinal cholecystokinin.
    Holmes BB, Rady JJ, Smith DJ, Fujimoto JM.
    Jpn J Pharmacol; 1999 Feb; 79(2):141-9. PubMed ID: 10202849
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Chronic administration of cholecystokinin antagonists reverses the enhancement of spinal morphine analgesia induced by acute pretreatment.
    Kellstein DE, Mayer DJ.
    Brain Res; 1990 May 21; 516(2):263-70. PubMed ID: 2364292
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cholecystokinin antagonizes morphine induced hypoactivity and hyperactivity in hamsters.
    Schnur P, Raigoza VP, Sanchez MR, Kulkosky PJ.
    Pharmacol Biochem Behav; 1986 Nov 21; 25(5):1067-70. PubMed ID: 3786358
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cholecystokinin potentiates morphine anticonvulsant action through both CCK-A and CCK-B receptors.
    Legido A, Adler MW, Karkanias C, Geller EB, Bradley E, Greenstein JI, Grover WD.
    Neuropeptides; 1995 Feb 21; 28(2):107-13. PubMed ID: 7746354
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of caerulein and CCK antagonists on tolerance induced to morphine antinociception in mice.
    Zarrindast MR, Zabihi A, Rezayat M, Rakhshandeh H, Ghazi-Khansari M, Hosseini R.
    Pharmacol Biochem Behav; 1997 Sep 21; 58(1):173-8. PubMed ID: 9264087
    [Abstract] [Full Text] [Related]

  • 18. Spinal co-administration of cholecystokinin antagonists with morphine prevents the development of opioid tolerance.
    Kellstein DE, Mayer DJ.
    Pain; 1991 Nov 21; 47(2):221-229. PubMed ID: 1762818
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. CCK receptor activation may prevent tolerance to morphine in mice.
    Rezayat M, Nikfar S, Zarrindast MR.
    Eur J Pharmacol; 1994 Mar 11; 254(1-2):21-6. PubMed ID: 8206114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.